Functional Imaging to Predict Tumor Response in Locally Advanced Cervical Cancer

被引:44
作者
Barwick, Tara D. [1 ,3 ]
Taylor, Alexandra [2 ]
Rockall, Andrea [1 ]
机构
[1] Imperial Coll Healthcare NHS Trust, Dept Radiol, London, England
[2] Royal Marsden Hosp Fdn NHS Trust, Dept Clin Oncol, London SW3 6JJ, England
[3] Imperial Coll Healthcare NHS Trust, Dept Imaging, Hammersmith Hosp, London W12 0HS, England
关键词
Cervical cancer; PET/CT; MRI; Diffusion-weighted imaging; Standardized uptake value; Apparent diffusion coefficient; Response assessment; Functional imaging; POSITRON-EMISSION-TOMOGRAPHY; APPARENT DIFFUSION-COEFFICIENT; STANDARDIZED UPTAKE VALUE; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; UTERINE CERVIX; LYMPH-NODES; F-18; FLUORODEOXYGLUCOSE; METABOLIC-RESPONSE; WEIGHTED MRI;
D O I
10.1007/s11912-013-0344-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Worldwide, cervical cancer is the third commonest cancer. Prognostic factors for cervical cancer include tumor size, histological subtype, histological grade, International Federation of Gynecology and Obstetrics (FIGO) stage, nodal status and performance status. However these known parameters are not sufficient to accurately predict treatment response or prognosis. There is a clinical need for noninvasive prognostic biomarkers to provide more detailed tumor characterization at the baseline and/or early during therapy, which may permit personalized treatment and potentially improve outcomes. Functional imaging techniques have been developing rapidly over the past decade. Imaging parameters derived from PET/CT and functional MRI techniques are emerging as promising response biomarkers. This review details the current evidence and future potential of functional imaging to predict tumor response in locally advanced cervical carcinoma.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 96 条
  • [1] Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
    不详
    [J]. NEOPLASIA, 2009, 11 (02): : 102 - 125
  • [2] [Anonymous], 2009, IMPLEMENTING IMAGE G
  • [3] Australia New Zealand Clinical Trials Registry, 2010, OUTBACK TRIAL
  • [4] Complete metabolic response after definitive radiation therapy for cervical cancer: Patterns and factors predicting for recurrence
    Beriwal, Sushil
    Kannan, Neeta
    Sukumyanich, Paniti
    Richard, Scott D.
    Kelley, Joseph L.
    Edwards, Robert P.
    Olawaiye, Alexander
    Krivak, Thomas C.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 127 (02) : 303 - 306
  • [5] Prediction of Patient Outcome With 2-Deoxy-2-[18F]fluoro-D-Glucose-Positron Emission Tomography Early During Radiotherapy for Locally Advanced Cervical Cancer
    Bjurberg, Maria
    Kjellen, Elisabeth
    Ohlsson, Tomas
    Bendahl, Par-Ola
    Brun, Eva
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (09) : 1600 - 1605
  • [6] Posttherapy surveillance of women with cervical cancer: An outcomes analysis
    Bodurka-Bevers, D
    Morris, M
    Eifel, PJ
    Levenback, C
    Bevers, MW
    Lucas, KR
    Wharton, JT
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 78 (02) : 187 - 193
  • [7] Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma
    Boss, EA
    Massuger, LFAG
    Verhoef, LCG
    Huisman, HJ
    Boonstra, H
    Barentsz, JO
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2001, 13 (04) : 600 - 606
  • [8] Cancer Research UK, 2012, CERV CANC INC STAT
  • [9] The utility of diffusion-weighted MR imaging in cervical cancer
    Chen Jianyu
    Zhang Yun
    Liang Biling
    Yang Zehong
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2010, 74 (03) : E102 - E107
  • [10] Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
    Chicklore, Sugama
    Goh, Vicky
    Siddique, Musib
    Roy, Arunabha
    Marsden, Paul K.
    Cook, Gary J. R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 133 - 140